MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Sleep disorders in progressive supranuclear palsy

    B. Muinjonov, E. Giyaziddinova (Tashkent, Uzbekistan)

    Objective: Assessment of incidence of insomnia in PSP, its connection with motor, neuropsychological and behavior disorders, evaluation of impact on the quality of life. Background:…
  • 2016 International Congress

    Association between clinical features and pre- and post-synaptic dopaminergic dysfunction in multiple system atrophy: [18F]-FP-CIT PET and [18F]-FDG PET analyses

    H.S. Ryu, M. Oh, M.J. Kim, S. You, Y.J. Kim, J. Kim, K. Kim, H. Moon, J. Oh, J.S. Kim, S.J. Chung (Seoul, Korea)

    Objective: To investigate the correlation between clinical features and pre- and post-synaptic dopaminergic dysfunction in patients with multiple system atrophy (MSA). Background: Multiple system atrophy…
  • 2016 International Congress

    Incidence of dystonia in patients with progressive supranuclear palsy

    E.I. Giyazitdinova, B.T. Muinjonov, G.S. Rakhimbaeva, Y.A. Musaeva (Taskent, Uzbekistan)

    Objective: To study the frequency of dystonic symptoms in progressive supranuclear palsy (PSP). Background: Progressive supranuclear palsy (PSP) is an uncommon brain disorder that affects…
  • 2016 International Congress

    Midbrain atrophy differentially progresses between Richardson’s Syndrome, progressive supranuclear palsy-parkinsonism and Parkinson’s disease: Longitudinal MRI study

    Y.E. Huh, M. Hwang, J.K. Park, J.W. Cho (Seoul, Korea)

    Objective: To elucidate different patterns of progression in midbrain atrophy between patients with Richardson's syndrome (PSP-RS), progressive supranuclear palsy-parkinsonism (PSP-P), and Parkinson's disease (PD) using…
  • 2016 International Congress

    Anti-LGI1 encephalitis presenting as a progressive supranuclear palsy-like syndrome

    G.A. Da Prat, E.M. Gatto, G.G. Persi, V. Parisi, D. Lisei, L. Rattagan, M. Bres Bullrich, S. Camerlingo, C. Rugilo, M. Titulaer, G. Rojas (Caba, Argentina)

    Objective: To describe a patient with a 12 –month history of progressive disorder suggestive of PSP-like syndrome, who was found to have anti-Leucin-rich Glioma Inactivated-1…
  • 2016 International Congress

    An elderly patient presenting as pure akinesia with gait freezing (PAGF): Idiopathic aqueductal stenosis-associated hydrocephalus

    K.Y. Kwon, J.J. Joo, B.J. Ahn, D.K. Yeo (Gumi, Kyeongsangbuk-do, Korea)

    Objective: Pure akinesia with gait freezing (PAGF)-mimicking disorders remain to be further elucidated. Background: Hydrocephalus is a poorly elucidated disorder. Aqueductal stenosis (AS) is a…
  • 2016 International Congress

    The condition of cerebral hemodynamics in the secondary vascular parkinsonism

    D. Akramova, A. Umarov, G. Rakhimbaeva, M. Ataniyazov, D. Shosaidova (Tashkent, Uzbekistan)

    Objective: To study influence of narrowing lesion of the main brain arteries to progress of secondary vascular stenosis prognosticate stenosis degree and prevent risk factors…
  • 2016 International Congress

    A cross-sectional study of sensor-based gait analysis in atypical Parkinsonian disorders

    C. Raccagni, H. Gassner, S. Eschlböck, S. Bösch, F. Krismer, M. Nocker, K. Seppi, W. Poewe, J. Klucken, G. Wenning (Innsbruck, Austria)

    Objective: Primary objective was to identify quantitative markers of gait impairment in patients with idiopathic Parkinson's disease (IPD), atypical Parkinsonian disorders (APD) and healthy controls…
  • 2016 International Congress

    MRI-supported diagnosis of multiple system atrophy: Implications for clinical trials

    F. Krismer, G.K. Wenning, S. Bajaj, M. Schocke, C. Scherfler, W. Poewe, K. Seppi (Innsbruck, Austria)

    Objective: To assess whether MSA-specific MRI changes predict a more rapid clinical decline in a cohort of patients with a clinical diagnosis of MSA. Background:…
  • 2016 International Congress

    Dorsal simultanagnosia as a cortical sign in the tauopathy spectrum

    B. Bergmans, O. Deryck, R. Bruffaerts (Brugge, Belgium)

    Objective: Clinical characterization of a tauopathy spectrum patient. Background: In recent years phenotypic overlap has been demonstrated between patients with progressive supranuclear palsy (PSP) pathology…
  • « Previous Page
  • 1
  • …
  • 1546
  • 1547
  • 1548
  • 1549
  • 1550
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley